Cerivastatin Sodium
| CAS No. | 143201-11-0 | Cat. No. | BCP21297 |
| Name | Cerivastatin Sodium | ||
| Synonyms | BAY-w-6228; BAY-w 6228; BAY-w6228; Rivastatin; | ||
| Formula | C26H33FNNaO5 | M. Wt | 481.54 |
| Description | Cerivastatin sodium is the sodium salt of cerivastatin. Cerivastatin is a statins used to lower cholesterol and prevent cardiovascular disease. It was marketed by the pharmaceutical company Bayer A.G. in the late 1990s. Cerivastatin was voluntarily withdrawn from the market worldwide in 2001, due to reports of fatal rhabdomyolysis. During postmarketing surveillance, 52 deaths were reported in patients using Cerivastatin, mainly from rhabdomyolysis and its resultant renal failure. | ||
| Pathways | Protease/Metabolic Enzyme | ||
| Targets | HMGCR | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.